Geode Capital Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-137,385
| Closed | -$7.55M | – | 5106 |
|
|
2022
Q2 | $7.55M | Buy |
137,385
+125,583
| +1,064% | +$6.59M | ﹤0.01% | 2447 |
|
|
2022
Q1 | $378K | Buy |
11,802
+1,727
| +17% | +$49.5K | ﹤0.01% | 4080 |
|
|
2021
Q4 | $219K | Hold |
10,075
| – | – | ﹤0.01% | 4437 |
|
|
2021
Q3 | $220K | Buy |
+10,075
| New | +$202K | ﹤0.01% | 4412 |
|
|
2020
Q1 | – | Sell |
-1,213
| Closed | -$16K | – | 4208 |
|
|
2019
Q4 | $16K | Hold |
1,213
| – | – | ﹤0.01% | 4175 |
|
|
2019
Q3 | $18K | Hold |
1,213
| – | – | ﹤0.01% | 4158 |
|
|
2019
Q2 | $27K | Buy |
1,213
+329
| +37% | +$15.9K | ﹤0.01% | 4143 |
|
|
2019
Q1 | $60K | Hold |
884
| – | – | ﹤0.01% | 3986 |
|
|
2018
Q4 | $46K | Hold |
884
| – | – | ﹤0.01% | 4005 |
|
|
2018
Q3 | $60K | Hold |
884
| – | – | ﹤0.01% | 4011 |
|
|
2018
Q2 | $104K | Hold |
884
| – | – | ﹤0.01% | 3860 |
|
|
2018
Q1 | $73K | Hold |
884
| – | – | ﹤0.01% | 3902 |
|
|
2017
Q4 | $131K | Hold |
884
| – | – | ﹤0.01% | 3763 |
|
|
2017
Q3 | $54K | Hold |
884
| – | – | ﹤0.01% | 3926 |
|
|
2017
Q2 | $41K | Sell |
884
-87
| -9% | -$4.44K | ﹤0.01% | 3986 |
|
|
2017
Q1 | $59K | Buy |
971
+633
| +187% | +$36.8K | ﹤0.01% | 3921 |
|
|
2016
Q4 | $20K | Buy |
338
+8
| +2% | +$499 | ﹤0.01% | 4002 |
|
|
2016
Q3 | $24K | Buy |
330
+2
| +0.6% | +$155 | ﹤0.01% | 3985 |
|
|
2016
Q2 | $26K | Hold |
328
| – | – | ﹤0.01% | 4004 |
|
|
2016
Q1 | $88 | Buy |
328
+58
| +21% | +$18.5K | ﹤0.01% | 3865 |
|
|
2015
Q4 | $162K | Buy |
270
+4
| +2% | +$2.71K | ﹤0.01% | 3753 |
|
|
2015
Q3 | $217K | Buy |
+266
| New | +$300K | ﹤0.01% | 3655 |
|
Other funds holding SRRA
Geode Capital Management's SRRA Position: Q3 2022 in Review
Geode Capital Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 137,385 shares — an estimated $7.55M sold.
Geode Capital Management first reported a position in SRRA in Q3 2015 and held it in 22 quarters. The position peaked at $7.55M in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.
- Geode Capital Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
- Geode Capital Management sold 137,385 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $7.55M.
- Geode Capital Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2015 and held it in 22 quarters.
- Geode Capital Management's Sierra Oncology, Inc. Common Stock position peaked at $7.55M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.
Based on Geode Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.